Skip to main content
SpringerLink
Log in

Prevention of type 1 diabetes: Where do we start?

  • Editorial
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med. 2002, 346: 1685–1691.

    Article  Google Scholar 

  2. Gale E.A.M.: The ENDIT trial final results: Lecture presented at EASD Congress, Budapest 2002.

    Google Scholar 

  3. Raz I., Elias D., Avron A., Tamir M., Metzger M., Cohen I.R. Betacell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001, 358: 1749–1753.

    Article  CAS  PubMed  Google Scholar 

  4. Herold K.C., Hagopian W., Auger J.A., et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 2002, 346: 1692–1698.

    Article  CAS  PubMed  Google Scholar 

  5. Hamalainen A.M., Ronkainen M.S., Akerblom H.K., Knip M. Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk. J. Clin. Endocrinol. Metab. 2000, 85: 4249–4253.

    CAS  PubMed  Google Scholar 

  6. Flavia N., L., Cotellessa M., et al. Screening for Type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention. (PREVEFIN study). Horm. Res. 2002, 58(2): 1–197.

    Google Scholar 

  7. Akerblom H.K., Vaarala O., Hyoty H., Ilonen J., Knip M. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 2002, 115: 18–29.

    Article  PubMed  Google Scholar 

  8. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int. Immunopharmacol. 2002, 2: 1017–1028.

    Article  CAS  PubMed  Google Scholar 

  9. Mathieu C., Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8: 174–179.

    Article  CAS  PubMed  Google Scholar 

  10. The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 1999, 42: 51–64.

    Article  Google Scholar 

  11. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., Virtanen S.M., Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358: 1500–1503.

    Article  CAS  PubMed  Google Scholar 

  12. Gregori S., Giarratana N., Smiroldo S., Uskokovic M., Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002, 51: 1367–1374.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Campus Bio-Medico, Rome, Italy

    P. Pozzilli

  2. Bioxell, Milan, Italy

    L. Adorini

Authors
  1. P. Pozzilli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Adorini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pozzilli, P., Adorini, L. Prevention of type 1 diabetes: Where do we start?. J Endocrinol Invest 26, 292–293 (2003). https://doi.org/10.1007/BF03345174

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345174

Search

Navigation